Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3Terminated 2

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Colposcopy × Clear all
NCT02067468 2019-09-19

ASCUS-COL

Universidad de Antioquia

Phase NA Completed
2,661 enrolled 18 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01131312 2018-11-20

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
5,060 enrolled 10 charts
Gynecologic

Uterine Cervical Dysplasia

NCT01944722 2018-06-12

Clinical Evaluation of the BD Onclarityâ„¢ HPV Assay on the BD Viperâ„¢ LT System With Cervical Specimens

Becton, Dickinson and Company

Phase NA Completed
33,858 enrolled 25 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡